FrancophonIA/ELRC3.0 huggingface dataset:
English: Rivastigmine Actavis may cause dizziness and somnolence, mainly at the start of treatment or when increasing the dose.
Icelandic: Rivastigmine Actavis getur valdið sundli og syfju, aðallega í upphafi meðferðar eða þegar skammtar eru stækkaðir.
English: The most commonly reported adverse reactions (ADRs) are gastrointestinal, including nausea (38 %) and vomiting (23 %), especially during titration.
Icelandic: Þær aukaverkanir sem oftast er greint frá tengjast meltingarfærum, þ.m.t. ógleði (38%) og uppköst (23%), einkum meðan verið er að stilla skammta af.
English: Dyskinesia Hypokinesia Cogwheel rigidity
Icelandic: Vélrænn stirðleiki í hreyfingum (cogwheel rigidity)
English: Based on evidence from animal studies the major cytochrome P450 isoenzymes are minimally involved in rivastigmine metabolism.
Icelandic: Samkvæmt upplýsingum úr in vitro rannsóknum og dýrarannsóknum koma helstu sýtókróm P450 ísóensímin óverulega að umbrotum rivastigmins.
English: Rivastigmine Actavis 1.5 mg hard capsules Rivastigmine Actavis 3 mg hard capsules Rivastigmine Actavis 4.5 mg hard capsules Rivastigmine Actavis 6 mg hard capsules rivastigmine
Icelandic: Rivastigmine Actavis 1,5 mg hörð hylki Rivastigmine Actavis 3 mg hörð hylki Rivastigmine Actavis 4,5 mg hörð hylki Rivastigmine Actavis 6 mg hörð hylki rivastigmin
English: Do not take Rivastigmine Actavis
Icelandic: Ekki má nota Rivastigmine Actavis
English: Rivastigmine works by blocking the enzymes that break down acetylcholine: acetylcholinesterase and butyrylcholinesterase.
Icelandic: Rivastigmin hefur áhrif með því að hamla virkni þeirra ensíma sem brjóta niður asetýlchólín: asetýlcholínesterasa og bútýrýlchólínesterasa.
English: Red iron oxide (E172)
Icelandic: Rautt járnoxíð (E172).
English: Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu
Icelandic: Upplýsingar sem hægt er að nálgast annarsstaðar Ítarlegar upplýsingar um lyfið eru birtar á vef Lyfjastofnunar Evrópu http://www.ema.europa.eu.
English: If you take more Rivastigmine Actavis than you should If you accidentally take more Rivastigmine Actavis than you should, inform your doctor.
Icelandic: Ef notaður er stærri skammtur en mælt er fyrir um Segðu lækninum ef þú hefur af slysni notað meira af Rivastigmine Actavis en þú áttir að gera.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Icelandic: Við meðgöngu, brjóstagjöf, grun um þungun eða ef þungun er fyrir huguð skal leita ráða hjá lækninum eða lyfjafræðingi áður en lyfiðer notað.
English: The capsules and oral solution can also be used for the treatment of dementia in adult patients with Parkinson's disease.
Icelandic: Hylkin og lausn til inntöku má einnig nota til meðferðar við vitglöpum hjá fullorðnum sjúklingum með Parkinsonsveiki.
English: Shellac, propylene glycol, red iron oxide (E172).
Icelandic: Gljálakk, própýlenglýkól, rautt járnoxíð (E172).
English: In peri/postnatal studies in rats, an increased gestation time was observed.
Icelandic: Í burðarmálsog eftirburðarrannsóknum hjá rottum var meðgangan lengri.
English: Caution when Rivastigmine Actavis is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions).
Icelandic: Gæta skal varúðar þegar Rivastigmine Actavis er tekið ásamt beta-blokkum (lyf eins og atenólól notuð við háþrýstingi, hjartaöng og öðrum hjartasjúkdómum).
English: Elevated liver function tests
Icelandic: Hækkuð lifrarpróf Lifrarbólga
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER Actavis Group PTC ehf.
Icelandic: NAFN OG HEIMILISFANG MARKAÐSLEYFISHAFA Actavis Group PTC ehf.
English: Patients with mild dementia dementia (MMSE 10-17)
Icelandic: Sjúklingar með væg vitglöp (MMSE 18-24)
English: Mean baseline ± SD 24.0 ± 10.3 24.5 ± 10.6 n/a n/a
Icelandic: Meðaltal grunngildis ± staðalfrávik 24,0 ± 10,3 24,5 ± 10,6
English: Capsule content: Magnesium stearate, colloidal anhydrous silica, hypromellose and microcrystalline cellulose.
Icelandic: Magnesíumsterat, vatnsfrí kísilkvoða, hýprómellósi og örkristallaður sellulósi.
English: How to take Rivastigmine Actavis
Icelandic: Hvernig nota á Rivastigmine Actavis
English: Metabolism and nutrition disorders Very common
Icelandic: Efnaskipti og næring Mjög algengar Algengar
English: Hard capsule (Capsule).
Icelandic: Hart hylki (hylki).
English: How to store Rivastigmine Actavis
Icelandic: Hvernig geyma á Rivastigmine Actavis
English: Since bradycardia constitutes a risk factor in the occurrence of torsades de pointes, the combination of rivastigmine with torsades de pointes-inducing medicinal products such as antipsychotics i.e. some phenothiazines (chlorpromazine, levomepromazine), benzamides (sulpiride, sultopride, amisulpride, tiapride, veralipride), pimozide, haloperidol, droperidol, cisapride, citalopram, diphemanil, erythromycin IV, halofantrin, mizolastin, methadone, pentamidine and moxifloxacine should be observed with caution and clinical monitoring (ECG) may also be required.
Icelandic: Vegna þess að hægsláttur er áhættuþáttur í framkomu margbreytilegs sleglahraðtakts (torsade de pointes) skal fylgjast vel með samhliðanotkun rivastigmins og lyfja sem leiða til margbreytilegs sleglahraðtakts svo sem geðrofslyf þ.e. sum fenothiazin (chlorpromazin, levomepromazin), benzamíð (sulpirid, sultoprid, amisulprid, tiaprid, veraliprid), pimozid, haloperidol, droperidol, cisaprid,
English: As a consequence of rivastigmine's interaction with its target enzyme, the increase in bioavailability is about 1.5-fold greater than that expected from the increase in dose.
Icelandic: Vegna milliverkana rivastigmins og markensímsins eykst aðgengi lyfsins 1,5 sinnum meira en sem samsvararstækkun skammta.
English: Pharmacotherapeutic group: psychoanaleptics, anticholinesterases, ATC code: N06DA03
Icelandic: Flokkun eftir verkun: Geðlyf (psychoanaleptica), kólínesterasahemlar, ATC flokkur:
English: Each Rivastigmine Actavis 6 mg capsule contains 6 mg of rivastigmine.
Icelandic: Hvert Rivastigmine Actavis 6 mg hylki inniheldur 6 mg af rivastigmini.
English: If you are pregnant, the benefits of using Rivastigmine Actavis must be assessed against the possible effects on your unborn child. Rivastigmine Actavis should not be used during pregnancy, unless clearly necessary.
Icelandic: Ef þú ert þunguð, verður að meta ávinninginn af notkun Rivastigmine Actavis á móti mögulegum neikvæðum áhrifum á hið ófædda barn.
English: • if you have, or have ever had, irregular or slow heartbeat.
Icelandic: ef þú ert með eða hefur fengið hjartsláttaróreglu eða hægan hjartslátt .
English: Each Rivastigmine Actavis 1.5 mg capsule contains 1.5 mg of rivastigmine.
Icelandic: Hvert Rivastigmine Actavis 1,5 mg hylki inniheldur 1,5 mg af rivastigmini.
English: Each Rivastigmine Actavis 3 mg capsule contains 3 mg of rivastigmine.
Icelandic: Hvert Rivastigmine Actavis 3 mg hylki inniheldur 3 mg af rivastigmini.
English: Mean baseline ± SD 23.8 ± 10.2 24.3 ± 10.5 n/a n/a
Icelandic: Meðaltal grunngildis ± staðalfrávik 23,8 ± 10,2 24,3 ± 10.5
English: Table 3 lists the number and percentage of patients from the specific 24-week clinical study conducted with rivastigmine in patients with dementia associated with Parkinson's disease with predefined adverse events that may reflect worsening of parkinsonian symptoms.
Icelandic: Í töflu 3 kemur fram fjöldi og hlutfall sjúklinga sem sýndu fyrirfram skilgreindar aukaverkanir sem gætu endurspeglað versnun einkenna Parkinsonsveiki í klínísku rannsókninni sem gerð var á notkun rivastigmins hjá sjúklingum með vitglöp í tengslum við Parkinsonsveiki og stóð yfir í 24 vikur.
English: • Inflammation of the pancreas - the signs include serious upper stomach pain, often with feeling sick (nausea) or being sick (vomiting)
Icelandic: Brisbólga - einkennin eru m.a. miklir verkir í efri hluta kviðar, oft með ógleði eða uppköstum
English: Table 2 shows the adverse reactions reported during clinical studies conducted in patients with dementia associated with Parkinson's disease treated with rivastigmine capsules.
Icelandic: 2 eru tilgreindar aukaverkanir sem greint var frá í klínískum rannsóknum sem gerðar voru hjá sjúklingum með vitglöp í Parkinsonsveiki sem fengu meðferð með rivastigmin hylkjum.
English: • if you have, or have ever had, impaired liver function.
Icelandic: ef þú ert með eða hefur verið með skerta lifrarstarfsemi.
English: Keep out of sight and reach of children.
Icelandic: Geymið þar sem börn hvorki ná til né sjá.
English: The following additional adverse reaction has been observed in a study of patients with dementia associated with Parkinson's disease treated with rivastigmine transdermal patches: agitation (common).
Icelandic: Eftirtalin aukaverkun, til viðbótar, hefur komið fram í rannsókn hjá sjúklingum með vitglöp í tengslum við Parkinsonsveiki sem meðhöndlaðir voru með rivastigmin forðaplástrum: æsingur (algeng).
English: Each Rivastigmine Actavis 4.5 mg capsule contains 4.5 mg of rivastigmine.
Icelandic: Hvert Rivastigmine Actavis 4,5 mg hylki inniheldur 4,5 mg af rivastigmini.
English: INFORMATION IN BRAILLE Rivastigmine Actavis 1.5 mg
Icelandic: UPPLÝSINGAR MEÐ BLINDRALETRI Rivastigmine Actavis 1,5 mg
English: associated with Parkinson's disease Total patients studied Total patients with pre-defined AE(s) Tremor
Icelandic: Heildarfjöldi sjúklinga í rannsókninni Heildarfjöldi sjúklinga sem fékk fyrirfram skilgreinda aukaverkun (aukaverkanir)
English: INFORMATION IN BRAILLE Rivastigmine Actavis 4.5 mg
Icelandic: UPPLÝSINGAR MEÐ BLINDRALETRI Rivastigmine Actavis 4,5 mg
English: Dementia associated with ADAS-Cog ADAS-Cog ADCS- CGIC ADCS-CGIC Parkinson's Disease
Icelandic: ADAS-Cog, sem er mat á skilvitlegri starfsemi og heildarmatið ADCS-CGIC (Alzheimer's disease cooperative studyclinician's global impression of change).
English: Dementia associated with ADAS-Cog ADAS-Cog ADAS-Cog ADAS-Cog Parkinson's Disease
Icelandic: ADAS-Cog ADAS-Cog ADAS-Cog ADAS-Cog Rivastigmin Lyfleysa Rivastigmin Lyfleysa
English: Rivastigmine Placebo Rivastigmine
Icelandic: Rivastigmin Lyfleysa Rivastigmin
English: Rivastigmine Actavis 6 mg hard capsules EU/1/11/693/013
Icelandic: Rivastigmine Actavis 6 mg hörð hylki EU/1/11/693/013
English: Rivastigmine Actavis 4.5 mg hard capsules EU/1/11/693/009
Icelandic: Rivastigmine Actavis 4.5 mg hörð hylki EU/1/11/693/009
English: Additionally there have been post-marketing cases of dizziness, tremor, headache, somnolence, confusional state, hypertension, hallucinations and malaise.
Icelandic: Auk þess hefur verið greint frá sundli, skjálfta, höfuðverk, svefnhöfga, ringlunarástandi, háþrýstingi ofskynjunum og lasleika eftir markaðssetningu lyfsins
English: The following additional adverse reactions have been observed with rivastigmine transdermal patches: delirium, pyrexia, decreased appetite, urinary incontinence (common), psychomotor hyperactivity (uncommon), erythema, urticaria, vesicles, allergic dermatitis (not known).
Icelandic: Að auki hefur verið greint frá eftirfarandi aukaverkunum við notkun á rivastigmin forðaplástrum: óráði, hita, minnkaðri matarlyst, þvagleka (algengar), skynhreyfiofvirkni (sjaldgæf), roða, ofsakláða, blöðrumyndun, ofnæmishúðbólga (tíðni ekki þekkt).
English: Titanium dioxide (E171) Yellow iron oxide (E172) Gelatine
Icelandic: Títantvíoxíð (E171), gult járnoxíð
English: Rivastigmine Actavis 1.5 mg hard capsules Titanium dioxide (E171) Yellow iron oxide (E172) Gelatine
Icelandic: Rivastigmine Actavis 1,5 mg hörð hylki Títantvíoxíð (E171).
English: • if you have, or have ever had, difficulties in passing urine.
Icelandic: ef þú átt í erfiðleikum eða hefur átt í erfiðleikum með þvaglát.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Icelandic: Notkun annarra lyfja samhliða Rivastigmine Acatavis Látið lækninn eða lyfjafræðing vita um önnur lyf sem eru notuð,hafa nýlega verið notuð eða kynnu að verða notuð.
English: - Rivastigmine Actavis 4.5 mg hard capsules, which contain off-white to slightly yellow powder, have a red cap and red body, with white imprint “RIV 4.5mg” on body.
Icelandic: - Rivastigmine Actavis 4,5 mg hörð hylki, sem innihalda beinhvítt til ljósgulleitt þurrefni, eru með rauðri hettu og rauðum bol, með hvítri áletrun „RIV 4.5mg“ á bolnum.
English: Rivastigmine Actavis is used for the treatment of adult patients with mild to moderately severe Alzheimer's dementia, a progressive brain disorder that gradually affects memory, intellectual ability and behaviour.
Icelandic: Rivastigmine Actavis er notað til meðferðar við minnistruflunum hjá fullorðnum sjúklingum með miðlungs til alvarleg vitglöp vegna Alzheimerssjúkdóms.
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 capsule contains 4.5 mg rivastigmine (as hydrogen tartrate).
Icelandic: VIRK(T) EFNI 1 hylki inniheldur 4,5 mg af rivastigmini (sem hýdrógentartrat).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR BLISTERS
Icelandic: SEM EIGA AÐ KOMA FRAM Á YTRI UMBÚÐUM ASKJA FYRIR GLÖS
English: Rivastigmine Actavis 3 mg hard capsules EU/1/11/693/005
Icelandic: Rivastigmine Actavis 3 mg hörð hylki EU/1/11/693/005
English: Patients with moderate
Icelandic: Sjúklingar með ofsjónir
English: Rivastigmine Actavis 1.5 mg hard capsules
Icelandic: Rivastigmine Actavis 1,5 mg hörð hylki
English: Reykjavíkurvegur 76-78 220 Hafnarfjörður Iceland
Icelandic: Reykjavíkurvegur 76-78 220 Hafnarfjörður
English: - Rivastigmine Actavis 6 mg hard capsules, which contain off -white to slightly yellow powder, have an red cap and orange body, with red imprint “RIV 6mg” on body.
Icelandic: - Rivastigmine Actavis 6 mg hörð hylki, sem innihalda beinhvítt til ljósgulleitt þurrefni, eru með rauðri hettu og appelsínugulum bol, með rauðri áletrun „RIV 6mg“ á bolnum.
English: INFORMATION IN BRAILLE Rivastigmine Actavis 3 mg
Icelandic: MEÐ BLINDRALETRI Rivastigmine Actavis 3 mg
English: If you get any side effects, talk to your doctor, pharmacist or nurse.
Icelandic: Ef ekki er ljóst hvernig nota á lyfið skal leita upplýsinga hjá lækninum, lyfjafræðingi eða hjúkrunarfræðing.
English: INFORMATION IN BRAILLE Rivastigmine Actavis 6 mg
Icelandic: MEÐ BLINDRALETRI Rivastigmine Actavis 6 mg
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 capsule contains 6 mg rivastigmine (as hydrogen tartrate).
Icelandic: VIRK(T) EFNI 1 hylki inniheldur 6 mg af rivastigmini (sem hýdrógentartrat).
English: • if you have, or have ever had, seizures.
Icelandic: ef þú ert með eða hefur fengið krampa.
English: Off-white to slightly yellow powder in a hard capsule with red cap and red body, with white imprint “RIV 4.5mg” on body.
Icelandic: Beinhvítt eða ljósgulleitt duft í hörðu hylki með rauðri hettu og rauðum bol, með hvítri áletrun „RIV 4.5mg“ á bolnum.
English: Capsule shell: Rivastigmine Actavis 1.5 mg hard capsules: Titanium dioxide (E171), yellow iron oxide (E172) and gelatine.
Icelandic: Rautt járnoxíð (E172), títantvíoxíð (E171), gult járnoxíð (E172) og gelatín.
English: Capsule content:
Icelandic: Innihald hylkisins:
English: There is no relevant use of Rivastigmine Actavis in the paediatric population in the treatment of Alzheimer's disease.
Icelandic: Notkun Rivastigmine Actavis á ekki við hjá börnum við meðferð við Alzheimerssjúkdómi.
English: Rivastigmine Actavis 6 mg hard capsules
Icelandic: Rivastigmine Actavis 6 mg hörð hylki.
English: However, rivastigmine may be used in this patient population and close monitoring is necessary.
Icelandic: Hinsvegar má nota rivastigmin hjá þessum sjúklingum ef haft er náið eftirlit með þeim.
English: Fatigue and asthenia
Icelandic: Þreyta og þróttleysi Vanlíðan
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/016
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/016
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/008
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/008
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 capsule contains 1.5 mg rivastigmine (as hydrogen tartrate).
Icelandic: VIRK(T) EFNI 1 hylki inniheldur 1,5 mg af rivastigmini (sem hýdrógentartrat).
English: Rivastigmine Actavis 3 mg hard capsules
Icelandic: Rivastigmine Actavis 3 mg hörð hylki.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/012
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/012
English: What Rivastigmine Actavis looks like and contents of the pack - Rivastigmine Actavis 1.5 mg hard capsules, which contain off-white to slightly yellow powder, have a yellow cap and yellow body, with red imprint “RIV 1.5mg” on body.
Icelandic: - Rivastigmine Actavis 1,5 mg hörð hylki, sem innihalda beinhvítt til ljósgulleitt þurrefni, eru með gulri hettu og gulum bol, með rauðri áletrun „RIV 1.5mg“ á bolnum.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/004
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/004
English: - Rivastigmine Actavis 3 mg hard capsules, which contain off-white to slightly yellow powder, have an orange cap and orange body, with red imprint “RIV 3mg” on body.
Icelandic: Rivastigmine Actavis 3 mg hörð hylki, sem innihalda beinhvítt til ljósgulleitt þurrefni, eru með appelsínugulri hettu og appelsínugulum bol, með rauðri áletrun „RIV 3mg“ á bolnum.
English: Printing ink:
Icelandic: Blek til áletrunar:
English: Off-white to slightly yellow powder in a hard capsule with red cap and orange body, with red imprint “RIV 6mg” on body.
Icelandic: Beinhvítt eða ljósgulleitt dufti í hörðu hylki með rauðri hettu og appelsínugulum bol, með rauðri áletrun „RIV 6mg“ á bolnum.
English: Shellac
Icelandic: Sundl
English: Rivastigmine Actavis 4.5 mg hard capsules
Icelandic: Rivastigmine Actavis 4,5 mg hörð hylki.
English: • if you have, or have ever had impaired kidney function.
Icelandic: ef þú ert með eða hefur verið með skerta nýrnastarfsemi.
English: Vascular disorders Very rare
Icelandic: Sjaldgæfar Mjög sjaldgæfar Koma örsjaldan fyrir
English: STATEMENT OF ACTIVE SUBSTANCE(S) 1 capsule contains 3 mg rivastigmine (as hydrogen tartrate).
Icelandic: VIRK(T) EFNI 1 hylki inniheldur 3 mg af rivastigmini (sem hýdrógentartrat).
English: Off-white to slightly yellow powder in a hard capsule with yellow cap and yellow body, with red imprint “RIV 1.5mg” on body.
Icelandic: Beinhvítt eða ljósgulleitt duft í hörðu hylki með gulri hettu og gulum bol, með rauðri áletrun „RIV 1.5mg“ á bolnum.
English: Allergic dermatitis (disseminated)
Icelandic: Dreifð ofnæmishúðbólga (útbreidd)
English: • if you have gastrointestinal reactions such as feeling sick (nausea), being sick (vomiting) and diarrhoea.
Icelandic: ef þú ert með einkenni frá meltingarvegi svo sem ógleði, uppköst og niðurgang.
English: By blocking these enzymes, Rivastigmine Actavis allows levels of acetylcholine to be increased in the brain, helping to reduce the symptoms of Alzheimer's disease and dementia associated with Parkinson's disease.
Icelandic: Með því að hamla virkni þessara ensíma , leyfir Rivastigmine Actavis magni asetýlchólíns að aukast aftur í heilanum, sem dregur úr einkennum
English: • The highest dose that should be taken is 6 mg twice a day.
Icelandic: Stærsti skammtur sem má nota er 6,0 mg tvisvar sinnum á sólarhring.
English: Nausea
Icelandic: Ofþ
English: Patients without visual hallucinations hallucinations
Icelandic: Sjúklingar með vitglöp og Parkinsonsveiki
English: Atrioventricular block
Icelandic: ADAS-Cog Rivastigmin
English: Rivastigmine Placebo Rivastigmine Placebo Patients with visual
Icelandic: UAB "Sicor Biotech"
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR CAPSULE CONTAINER
Icelandic: SEM EIGA AÐ KOMA FRAM Á YTRI UMBÚÐUM ASKJA FYRIR ÞYNNUR
English: Infections and infestations Very rare
Icelandic: Húð og undirhúð Algengar Mjög sjaldgæfar Tíðni ekki þekkt
English: The ink may or may not contain potassium hydroxide.
Icelandic: Blekið getur innihaldið natríumhýdroxíð.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/013[ 28 blister]
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/013[ 28 þynna] EU/1/11/693/014 [56 þynna] EU/1/11/693/015 [112 þynna]
English: There is no relevant use of rivastigmine in the paediatric population in the treatment of Alzheimer's disease.
Icelandic: Notkun rivastigmins á ekki við hjá börnum við meðferð við Alzheimerssjúkdómi.
English: Rivastigmine might interfere with the activity of anticholinergic medicinal products (e.g oxybutynin, tolterodine).
Icelandic: Með tilliti til lyfhrifa og hugsanlegra samlegðaráhrifa ætti ekki að nota rivastigmin samhliða öðrum kólínvirkum efnum Rivastigmin getur truflað verkun andkólínvirkra lyfja (t.d. oxybutynins, tolterodins).
English: You may become dehydrated (losing too much fluid) if vomiting or diarrhoea are prolonged.
Icelandic: • ofþornað (misst of mikinn vökva) ef uppköst og niðurgangur eru viðvarandi.
English: Other medicines and Rivastigmine Actavis
Icelandic: AÐFERÐ VIÐ LYFJAGJÖF OG ÍKOMULEIÐ(IR)
English: Off-white to slightly yellow powder in a hard capsule with orange cap and orange body, with red imprint “RIV 3mg” on body.
Icelandic: Beinhvítt eða ljósgulleitt duft í hörðu hylki með appelsínugulri hettu og appelsínugulum bol, með rauðri áletrun „RIV 3mg“ á bolnum.
English: Parkinson gait
Icelandic: B. FYLGISEÐILL
English: Salivary hypersecretion
Icelandic: Örkristölluð sellulósa
English: Adjusted treatment difference p-value versus placebo n/a
Icelandic: Aðlagaður meðferðarmunur p-gildi samanborið við lyfleysu n/a
English: Balance disorder Musculoskeletal stiffness Rigors
Icelandic: Svefnleysi Þunglyndi Ofskynjanir
English: Bradykinesia
Icelandic: Brjóstsviði
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING LABEL FOR CAPSULE CONTAINER
Icelandic: Lýsing á útliti Rivastigmine Actavis og pakkningastærðir
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/005[ 28 blister]
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/005[ 28 þynnur] EU/1/11/693/006 [56 þynnur] EU/1/11/693/007 [112 þynnur]
English: Maintenance dose
Icelandic: Notkun lyfsins
English: MARKETING AUTHORISATION NUMBER(S) EU/1/11/693/009[ 28 blister]
Icelandic: MARKAÐSLEYFISNÚMER EU/1/11/693/001[ 28 þynna] EU/1/11/693/002 [56 þynna] EU/1/11/693/003 [112 þynna]
English: Anxiety
Icelandic: rivastigmin
English: Hypokinesia
Icelandic: LYFJAFORM
English: Patients with dementia and Parkinson's disease These patients have some side effects more often.
Icelandic: Alzheimer sjúkdómsins og þeim vitglöpum sem tengjast Parkinson sjúkdómnum.
English: What you need to know before you take Rivastigmine Actavis
Icelandic: Áður en byrjað er að nota Rivastigmine Actavis
English: Uncommon (may affect up to 1 in 100 people) • Hyperactivity (high level of activity, restlessness)
Icelandic: Ofvirkni (of mikil virkni, eirðarleysi)
English: 1 pre-filled pen + 7 NovoTwist needles
Icelandic: 7 NovoTwist nálar
English: 5 pre-filled pens
Icelandic: 5 áfylltir lyfjapennar
English: 1 pre-filled pen + 7 NovoFine needles
Icelandic: 7 NovoFine nálar
English: Invented name Strength Pharmaceutical form Route of administration Packaging
Icelandic: (Sér)heiti Styrkleiki
English: --1 1 dose (0.5 ml) contains:
Icelandic: Einn skammtur (0,5 ml) inniheldur:
English: Recombinant lipidated fHbp (factor H binding protein) Produced in Escherichia coli cells by recombinant DNA technology Adsorbed on aluminium phosphate (0.25 milligram aluminium per dose)
Icelandic: Lípíðtengt fHbp (prótein sem bindur H-þátt), framleitt með erfðatækni Framleitt með erfðatækni í E. coli frumum Aðsogað á álfosfat (0,25 milligrömm af áli í hverjum skammti)
English: Neisseria meningitidis serogroup B fHbp subfamily B
Icelandic: Neisseria meningitidis gerð B fHbp undirætt B
English: Neisseria meningitidis serogroup B fHbp subfamily A
Icelandic: Neisseria meningitidis gerð B fHbp undirætt A
English: 1 pre-filled syringe with needle
Icelandic: 1 áfyllt sprauta með nál
English: (Invented) name Strength Pharmaceutical form
Icelandic: ESB markaðsleyfisnúmer (Sér)heiti Styrkleiki
English: Phone: +34 (0) 914856756
Icelandic: Sími: +34 (0) 914856756
English: Efficacy data demonstrated an effect from 35 days after treatment.
Icelandic: Upplýsingar um verkun sýna áhrif frá 35 dögum eftir meðferð.
English: Use a 20G needle.
Icelandic: Notið 20G nál.
English: MARKETING AUTHORISATION NUMBER(S) EU/2/18/226/001
Icelandic: 16. MARKAÐSLEYFISNÚMER EU/2/18/226/001